|
Name |
Cyclobutaneethanol, 2-isopropenyl-1-methyl-, cis-(+)-
|
Molecular Formula | C10H18O | |
IUPAC Name* |
2-[(1R,2R)-1-methyl-2-prop-1-en-2-ylcyclobutyl]ethanol
|
|
SMILES |
CC(=C)[C@H]1CC[C@]1(C)CCO
|
|
InChI |
InChI=1S/C10H18O/c1-8(2)9-4-5-10(9,3)6-7-11/h9,11H,1,4-7H2,2-3H3/t9-,10-/m1/s1
|
|
InChIKey |
SJKPJXGGNKMRPD-NXEZZACHSA-N
|
|
Synonyms |
Fragranol; Cyclobutaneethanol, 2-isopropenyl-1-methyl-, cis-(+)-; Cyclobutaneethanol, 1-methyl-2-(1-methylethenyl)-, trans-; Cyclobutaneethanol, 2-isopropenyl-1-methyl-, stereoisomer; Cyclobutaneethanol, 1-methyl-2-(1-methylethenyl)-, (1R-cis)-; SCHEMBL7708509; 2-(2-Isopropenyl-1-methylcyclobutyl)ethanol #; Q67879891; (1R)-1-Methyl-2beta-isopropenylcyclobutane-1alpha-ethanol
|
|
CAS | NA | |
PubChem CID | 6432285 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 154.25 | ALogp: | 2.9 |
HBD: | 1 | HBA: | 1 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 20.2 | Aromatic Rings: | 1 |
Heavy Atoms: | 11 | QED Weighted: | 0.619 |
Caco-2 Permeability: | -4.356 | MDCK Permeability: | 0.00001940 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.43 |
30% Bioavailability (F30%): | 0.012 |
Blood-Brain-Barrier Penetration (BBB): | 0.993 | Plasma Protein Binding (PPB): | 51.98% |
Volume Distribution (VD): | 1.3 | Fu: | 54.32% |
CYP1A2-inhibitor: | 0.117 | CYP1A2-substrate: | 0.805 |
CYP2C19-inhibitor: | 0.061 | CYP2C19-substrate: | 0.809 |
CYP2C9-inhibitor: | 0.048 | CYP2C9-substrate: | 0.571 |
CYP2D6-inhibitor: | 0.008 | CYP2D6-substrate: | 0.715 |
CYP3A4-inhibitor: | 0.027 | CYP3A4-substrate: | 0.241 |
Clearance (CL): | 6.964 | Half-life (T1/2): | 0.654 |
hERG Blockers: | 0.013 | Human Hepatotoxicity (H-HT): | 0.044 |
Drug-inuced Liver Injury (DILI): | 0.033 | AMES Toxicity: | 0.006 |
Rat Oral Acute Toxicity: | 0.023 | Maximum Recommended Daily Dose: | 0.065 |
Skin Sensitization: | 0.272 | Carcinogencity: | 0.08 |
Eye Corrosion: | 0.979 | Eye Irritation: | 0.988 |
Respiratory Toxicity: | 0.131 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000852 | 0.349 | D07QKN | 0.196 | ||||
ENC003255 | 0.321 | D0H1QY | 0.184 | ||||
ENC001895 | 0.308 | D0O1UZ | 0.179 | ||||
ENC001925 | 0.308 | D0C1QZ | 0.179 | ||||
ENC000453 | 0.294 | D04VIS | 0.169 | ||||
ENC000369 | 0.283 | D0B4RU | 0.163 | ||||
ENC000786 | 0.273 | D00VZZ | 0.163 | ||||
ENC002392 | 0.273 | D0S7WX | 0.162 | ||||
ENC001284 | 0.261 | D0W6DG | 0.160 | ||||
ENC000411 | 0.261 | D04SFH | 0.155 |